Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
9.80
-0.01 (-0.10%)
Feb 13, 2026, 3:04 PM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 3.97 billion as of February 13, 2026. Its market cap has increased by 19.03% in one year.
Market Cap
3.97B
Enterprise Value
3.82B
Revenue
251.83M
Ranking
n/a
PE Ratio
134.15
Stock Price
9.80
Market Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 3.97B, a decrease of -72.52%. That is a compound annual growth rate of -22.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.97B | 4.14% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.47B |
| Hinova Pharmaceuticals | 4.47B |
| Guanhao Biotech | 4.15B |
| Zhejiang Wecome Pharmaceutical Company | 4.12B |
| Zhejiang Shouxiangu Pharmaceutical | 4.10B |
| Boji Medical Technology | 4.05B |
| Shanghai Shen Lian Biomedical | 3.97B |
| Baolingbao Biology | 3.97B |